AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02981381 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM
Description: The SHAM NeoSync EEG Synchronized TMS (NEST) is a device, identical to the active NEST-1 device, that is configured to simulate the delivery of active treatment without actively delivering sTMS therapy. The device includes an EEG recording module that is used to record individualized alpha frequency (IAF) on randomized personal passport modules (PPM) pre-assigned to be SHAM compatible.
Study NCT02981381 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NEST-2
Description: The open-label NeoSync EEG Synchronized TMS (NEST) that produces and delivers a sinusoidal magnetic field to areas of the brain in the treatment of PTSD. The device is distinct in both color and sound both SHAM and NEST-1 devices. PPMs corresponding with both SHAM and NEST-1 devices are compatible with the NEST-2 device.
Study NCT02981381 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: NEST-2
Description: The open-label NeoSync EEG Synchronized TMS (NEST) that produces and delivers a sinusoidal magnetic field to areas of the brain in the treatment of PTSD. The device is distinct in both color and sound both SHAM and NEST-1 devices. PPMs corresponding with both SHAM and NEST-1 devices are compatible with the NEST-2 device.
Study NCT02672384 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dental examination and a point of care P. gingivalis test (Denka Seiken Co (Japan) )
Description: Dental examination Study exams (oral and blood sample collection)
Study NCT04389502 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CaPtyVa app
Description: The apps stores all the current local Clinical practice guidelines information related to CRC screening and surveillance and through its decision algorithms assist physicians in the screening process. In the screening function, CaPtyVa helps the physicians to classify patient´s according to their individual CRC risk and to determine how and when to start with screening tests. In the surveillance, function the app assist the physician in determining when to repeat the next colonoscopy according to guideline recommendation
Study NCT04389502 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: current physician knowledge on local current CRC screening and surveillance guidelines
Study NCT00547287 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tadalafil
Description: 20 mg tadalafil as needed by mouth no more than once a day for a 4 week initiation period and a 4 weeks treatment period.
Study NCT00547287 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sildenafil
Description: Current dosage of sildenafil is continued for 4 weeks (no more than once a day) of treatment assessment then the wash-out period will begin.
Study NCT03062774 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PB-119 injection
Study NCT04028310 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Phonological
Description: * Phase 1: intervention without targeted daily training (30 minutes/ week, for 8 weeks)~* Phase 2: intervention with targeted daily training~  * Phonological training (15 minutes/ day, 5 days/week, for 8 weeks)~ * Visuo-attentional training (15 minutes/ day, 5 days/week, for 8 weeks)~ * Cross-modal training (15 minutes/ day, 5 days/week, for 8 weeks)~* Phase 3: stopping training sessions for 8 weeks
Study NCT04028310 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual-attention
Description: * Phase 1: intervention without targeted daily training (30 minutes/ week, for 8 weeks)~* Phase 2: intervention with targeted daily training~  * Visuo-attentional training (15 minutes/ day, 5 days/week, for 8 weeks)~ * Phonological training (15 minutes/ day, 5 days/week, for 8 weeks)~ * Cross-modal training (15 minutes/ day, 5 days/week, for 8 weeks)~* Phase 3: stopping training sessions for 8 weeks
Study NCT00084643 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GTI-2040
Description: Given IV
Study NCT00084643 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxaliplatin
Description: Given IV
Study NCT00084643 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine
Description: Given orally
Study NCT00084643 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT00084643 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT02675790 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moderate Dose Hydroxyurea
Description: Hydroxyurea therapy at 20 mg/kg/day for primary stroke prevention.
Study NCT02675790 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Low Dose Hydroxyurea
Description: Hydroxyurea therapy at 10 mg/kg/day (range 7 - 15 mg/kg/day) for primary stroke prevention.
Study NCT00871884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: Education about the common prognostic considerations, normal symptoms experienced and etiology of symptoms following mild head injury. Includes some basic suggestions surrounding methods to diminish the impact of symptoms on one's life.
Study NCT00871884 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: Education about the common prognostic considerations, normal symptoms experienced and etiology of symptoms following mild head injury. Includes some basic suggestions surrounding methods to diminish the impact of symptoms on one's life.
Study NCT00871884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relaxation Training
Description: Includes Progressive Muscle Relaxation, Guided Visualization, and various other relaxation techniques to induce deep relaxation.
Study NCT00871884 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relaxation Training
Description: Includes Progressive Muscle Relaxation, Guided Visualization, and various other relaxation techniques to induce deep relaxation.
Study NCT00871884 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interoceptive Exposure
Description: Includes a variety of exercises used to elicit somatic sensations which may be feared by the participant, in an attempt to extinguish or lessen the fear reaction to these sensations.
Study NCT04105530 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Anodal tDCS treatment
Description: The Anodal intervention excites neuronal activity. For condition one, the anode will be attached to the left frontal region (Fp1) and the cathode will be attached to the right neck. The intervention involves a direct current of 1 mA applied for 20 minutes.
Study NCT04105530 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cathodal tDCS treatment
Description: The Cathodal intervention inhibits or reduces neuronal activity. We propose that the use of the cathodal tDCS to the superior temporal gyrus in survivors of childhood ALL may facilitate the inhibition of over connected motor-sensory and auditory neural networks. For condition two, the cathode will be attached to the left temporal region (T3) and the anode will be attached to the right neck. The intervention involves a direct current of 1 mA applied for 20 minutes.
Study NCT04105530 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham treatment
Description: The sham procedure provides the same small current during ramp up to imitate the intervention, but the current is discontinued after ramping up and no intervention is provided. Sham will be applied for 20 minutes. Stimulation will start 5 minutes before testing and continue throughout completing the NIH Toolbox Cognitive Battery at each trial.
Study NCT01365351 — intervention group
Intervention type: OTHER
Intervention: Growth hormone
Description: Drug given by prescription
Study NCT04105530 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: NIH Toolbox List Sorting Working Memory Test
Description: List Sorting is using information processing and storage. Performance tends to peak in early adulthood and then decline across the life span. This task assesses working memory and requires the participant to sequence different visually- and orally-presented stimuli. The list scoring task takes approximately 7 minutes to administer. List Sorting is scored by summing the total number of items correctly recalled and sequenced on Lists-1 and -2, which can range from 0-26.
Study NCT04105530 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NIH Toolbox List Sorting Working Memory Test
Description: List Sorting is using information processing and storage. Performance tends to peak in early adulthood and then decline across the life span. This task assesses working memory and requires the participant to sequence different visually- and orally-presented stimuli. The list scoring task takes approximately 7 minutes to administer. List Sorting is scored by summing the total number of items correctly recalled and sequenced on Lists-1 and -2, which can range from 0-26.
Study NCT04105530 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: NIH Toolbox Flanker Inhibitory Control and Attention Test
Description: The Flanker tests inhibitory control and attention and the capacity for new learning and information processing novel situations. This performance also reaches a peak in early adulthood and tends to decline across the life span. A total of 40 trials require 4 minutes. Scoring is based on both accuracy and reaction time, which will we evaluate individually as well as in combination. The raw scores are converted to a scale score with a mean of 100 and SD of 15. Higher scores indicate higher executive function.
Study NCT04105530 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NIH Toolbox Flanker Inhibitory Control and Attention Test
Description: The Flanker tests inhibitory control and attention and the capacity for new learning and information processing novel situations. This performance also reaches a peak in early adulthood and tends to decline across the life span. A total of 40 trials require 4 minutes. Scoring is based on both accuracy and reaction time, which will we evaluate individually as well as in combination. The raw scores are converted to a scale score with a mean of 100 and SD of 15. Higher scores indicate higher executive function.
Study NCT04105530 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Grooved Peg Board Test
Description: The Grooved Peg Board test measures visual-motor coordination and motor speed. Additionally, it is cognitively challenging and has been associated with attention, perceptual speed and non-verbal reasoning. Performance is better in the dominant/preferred hand and tends to improve in childhood and decline with advancing age. The test consists of placing metal pegs with ridges along onside in matching slots as quickly as possible. The score is the time in seconds required to compete the array with each hand. Longer times reflect worse performance. Times are compared to normative data that is organized by ethnicity, age, gender and education. The test takes approximately 5 minutes to complete.
Study NCT04105530 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Grooved Peg Board Test
Description: The Grooved Peg Board test measures visual-motor coordination and motor speed. Additionally, it is cognitively challenging and has been associated with attention, perceptual speed and non-verbal reasoning. Performance is better in the dominant/preferred hand and tends to improve in childhood and decline with advancing age. The test consists of placing metal pegs with ridges along onside in matching slots as quickly as possible. The score is the time in seconds required to compete the array with each hand. Longer times reflect worse performance. Times are compared to normative data that is organized by ethnicity, age, gender and education. The test takes approximately 5 minutes to complete.
Study NCT04105530 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Buschke Selective Reminding Test
Description: This selective reminding task purports to distinguish verbal memory into short-term and long-term components. Scores are organized by short- and long-term storage and retrieval with normative scores organized by age and gender. The task requires participants to remember a list of orally-presented words and recall them with selective reminders of the words that they didn't recall. The test will last 5-10 minutes and is available in four different versions, thus reducing rehearsal effects.
Study NCT04105530 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Buschke Selective Reminding Test
Description: This selective reminding task purports to distinguish verbal memory into short-term and long-term components. Scores are organized by short- and long-term storage and retrieval with normative scores organized by age and gender. The task requires participants to remember a list of orally-presented words and recall them with selective reminders of the words that they didn't recall. The test will last 5-10 minutes and is available in four different versions, thus reducing rehearsal effects.
Study NCT01622543 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Folfox plus Bevacizumab and reolysin
Description: FOLFOX6/bevacizumab given every 14 days plus reolysin days 1-5 on cycles 1, 2, 4, 6, 8 and alternate cycles thereafter
Study NCT01622543 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Folfox plus Bevacizumab
Description: FOLFOX6/bevacizumab given every 14 days.
Study NCT05512429 — intervention group
Intervention type: OTHER
Intervention: measured of body composition with computed tomography
Description: Multislice and single-slice computed tomography images were used for assessment of body composition including visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), skeletal muscle mass volume (SMMV)
Study NCT00735865 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Punctal plugs, punctal cautery
Description: 25 subjects(20 silicone punctal plugs, 5 punctal cautery) The procedure will be based on clinical indication. Randomized one eye for study. Baseline cultures of lid margin \& tarsal/inferior fornix conjunctiva obtained \& plated according to protocol
Study NCT00735865 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Punctal Plug, Punctal thermocauterization
Description: Up to 5 subjects. Subjects in need of punctal occlusion(No preference for punctal thermocauterization or punctal occlusion by silicone plug). Randomize one eye to silicone punctal plug occlusion, the other eye to punctal thermocauterization.~This group ONLY, cultures will be obtained of the lid margin \& conjunctiva/inferior fornix of BOTH eyes
Study NCT00735865 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Silicone plug or thermodynamic hydrophobic acrylic plug
Description: Up to 5 subjects. Subjects in need of punctal occlusion(not preference for punctal occlusion by silicone plug or by the thermodynamic hydrophobic acrylic plug). Randomize one eye to silicone punctal plug occlusion, the other eye to acrylic punctal plug occlusion.~In this group ONLY cultures will be obtained of the lid margin and conjunctiva/inferior fornix of BOTH eyes
Study NCT00735865 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Previous subjects with Punctal occlusion
Description: Up to 20 subjects(15 subjects with silicone punctal plug closure and 5 subjects with punctal closure by thermocauterization)Subjects who have previously had punctal occlusion who have symptoms and/or signs thought to be secondary to punctal occlusion.~Lid margin and conjunctiva/inferior fornix of eye with greatest sign or symptoms will be cultured/plated according to standard protocol.
Study NCT03076372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MM-310
Description: MM-310
Study NCT03654339 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: root coverage
Description: Group A: After administration of local anaesthesia using ophthalmic microsurgical knives a V-shaped incision was made in the gingival recession area. the gingiva was removed .the adjacent partial thickness pedicle flap was reflected from the donor area .the pedicle flap was then covered over the recipient site. then secured with 6-0 absorbable sling suture without tension. the surgical procedure was done with seilar microscope 40X magnification.~Group B: After administration of local anaesthesia using 15 no blade a V-shaped incision was made in the gingival recession area . gingiva was removed .the adjacent partial thickness pedicle flap was reflected from the donor area .the pedicle flap was then covered over the recipient site. then carefully secured with 4-0 absorbable sling suture
Study NCT02487550 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DC-CIK
Description: Patients with renal cell carcinoma will receive autologous dendritic cells loaded with autologous tumor lysate (dendritic cell vaccine) by venous infusion of CIK cells.
Study NCT02487550 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: IL-2/IFN-α
Description: Patients with renal cell carcinoma will receive IL-2/IFN-α by venous infusion.
Study NCT03170245 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Interleukin-6
Description: serum samples used for doing the test by ELISA
Study NCT03170245 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: HsC-RP
Description: serum samples used for doing the test by ELISA
Study NCT03170245 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Adiponectin level
Description: serum samples used for doing the test by ELISA
Study NCT03170245 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Carotid intima media thickness
Description: Done by carotid doppler
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Clinician Valgus
Description: Clinician performed valgus stress X-ray under fluoroscopy
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Clinician Varus
Description: Clinician performed varus stress X-ray under fluoroscopy
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Device Valgus - 0 Newton
Description: Device (Oxford Stress System for Knee Arthroplasty Radiographs (OSSKAR)) performed valgus stress X-ray under fluoroscopy.
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Device Valgus - 10 Newton
Description: Device (Oxford Stress System for Knee Arthroplasty Radiographs (OSSKAR)) performed varus stress X-ray under fluoroscopy.
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Device Valgus - 20 Newton
Description: Device (Oxford Stress System for Knee Arthroplasty Radiographs (OSSKAR)) performed valgus stress X-ray under fluoroscopy.
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Device Valgus - 30 Newton
Description: Device (Oxford Stress System for Knee Arthroplasty Radiographs (OSSKAR)) performed valgus stress X-ray under fluoroscopy.
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Device Varus - 0 Newton
Description: Device (Oxford Stress System for Knee Arthroplasty Radiographs (OSSKAR)) performed valgus stress X-ray under fluoroscopy.
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Device Varus - 10 Newton
Description: Device (Oxford Stress System for Knee Arthroplasty Radiographs (OSSKAR)) performed valgus stress X-ray under fluoroscopy.
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Device Varus - 20 Newton
Description: Device (Oxford Stress System for Knee Arthroplasty Radiographs (OSSKAR)) performed valgus stress X-ray under fluoroscopy.
Study NCT02444663 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Device Varus - 30 Newton
Description: Device (Oxford Stress System for Knee Arthroplasty Radiographs (OSSKAR)) performed valgus stress X-ray under fluoroscopy.
Study NCT03202095 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Creatine Monohydrate
Description: 5 grams daily of oral creatine monohydrate powder.
Study NCT01737684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vibegron
Description: 50 mg tablet, oral
Study NCT01756521 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Study NCT01756521 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Moxifloxacin
Study NCT00877981 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimal invasive Parathyroid surgery
Study NCT02462850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CL-108
Study NCT00958022 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBH589 and carboplatin with etoposide
Description: LBH589 will be given in oral formulation starting at a dose of 10 mg (Dose Level 1) 3x/week (2 days apart, e.g. Mon, Wed, Fri), during 2 weeks out of 3-weekly dosing schedule. After establishing the MTD at a 2 out 3 weeks dosing schedule, a 3 out of 3 weeks dosing schedule will be tested at that dose. This schedule will be adopted in the absence of limiting toxicities. Will be continued weekly after completion of 6 cycles of combo chemotherapy until progression or intolerable toxicities.~Etoposide: Cycles 1-6: 100 mg/m² IV over 60 mins, Days 1-3 every 21 days for 6 cycles Carboplatin: commercially available as a sterile lyophilized powder available in single dose vials containing 50mg, 150mg, or 450mg of carboplatin. Each vial contains equal parts by weight of carboplatin \& mannitol. Commercial supplies will be used for this study. It will be administered as an i.v. infusion over 30 minutes. The dose will be calculated based on patient's body weight at each treatment visit.
Study NCT04499716 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IPACK
Description: 25 milliliters of ropivacaine 0.3% will be injected between popliteal artery and femur.
Study NCT04499716 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Femoral triangle block
Description: 25 milliliters of ropivacaine 0.3% will be injected on the lateral side of the femoral artery at the distal part of the femoral triangle.